Treatment of Anal Incontinence With Intersphincteric Implants

Status Terminated

Clinical Trial Summary

The purpose of this study is to determine whether treatment with intersphincteric implants is an effective and safe treatment option for patients with anal incontinence

Clinical Trial Description

Treatment of anal incontinence (AI) remains a challenge - although conservative treatment can reduce the severity of many patients' AI, many continue to experience symptoms that severly affect their quality of life and ability to function properly both socially and professionally. The level of AI is measured with the St Marks score (ranging from 0-24 where zero is complete continence). Some patients with AI are shown to have defects in the anal sphincters (i.e. traumatic lesions post partum) and can be helped with reconstructive surgery. These procedures are effective but carry substantial risk for postoperative infection, and the healing process is painful. One of the main treatment options for anal incontinence today is Sacral Nerve Stimulation (SNS), which is an effective but invasive and expensive treatment with a rather high level of infection. It is normally performed in two separate sessions and require life-long follow up and new surgical procedures every 6-7 years. Historically artificial anal sphincters have been studied and shown to be effective but with high rates of infections leading to removal of the device. In more recent years studies have instead focused on "bulking agents" (injection of i.e. silicone in the submucosal space with the aim to increase the resting pressure of the anal canal), but the effect seems to be limited and the agents injected are rapidly resorbed by the body. Treatment with intersphincteric implants is a novel treatment option for these patients. Available studies have shown good results regarding effect and a low frequence of postoperative infections. The implants rarely dislocate and are not resorbed by the body, which contributes to their long-term effectiveness. The operation is performed under a short general anaesthesia and in available studies the postoperative symptoms are few. The first technique described was called Gatekeeper (six implants), and this has since been completed by the Sphinkeeper (ten implants), which is the focus of the present study. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT03080753
Study type	Interventional
Source	Region Skane
Contact
Status	Terminated
Phase	N/A
Start date	October 11, 2017
Completion date	October 1, 2019

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT03825575` - Sacral Neuromodulation as Treatment for Fecal Incontinence	N/A
Completed	`NCT00605826` - A Randomized, Blinded, Multicenter Study to Evaluate NASHA/Dx for the Treatment of Fecal Incontinence	N/A
Withdrawn	`NCT02208258` - Efficacy, Safety, and Performance Study of a Novel Device Designed to Manage Fecal Incontinence in Hospitalized Bedridden Patients With Liquid to Semi-formed Stool.	N/A
Completed	`NCT01957969` - French Post-Inscription Study on Sacral Neuromodulation in the Treatment of Fecal Incontinence	N/A
Completed	`NCT01939821` - A Pilot Study to Evaluate Educational Programs to Improve Fecal Incontinence Care in Nursing Homes	N/A
Completed	`NCT01710579` - Normal Values in Ano-rectal 3D High Resolution Manometry	N/A
Recruiting	`NCT00530933` - Tibial Nerve Stimulation for Faecal Incontinence	N/A
Withdrawn	`NCT00522691` - Efficacy of Sacral Nerve Stimulation Before Definitive Implantation	N/A
Completed	`NCT00565136` - Evaluation of Outcomes of Restoring Pelvic Floor Support With TOPAS in Women With Moderate Fecal Incontinence Symptoms	Phase 1/Phase 2
Completed	`NCT00677508` - Development of an Instrument to Measure Quality of Life in Children With Chronic Constipation and Soiling
Completed	`NCT05032534` - Examination of a New Irrigation System for Transanal Irrigation in Children With Fecal Incontinence	N/A
Completed	`NCT05058326` - Severity of Fecal Incontinence and Manometric Values Using the Anopress® Device in Women
Completed	`NCT03746834` - NASHA/Dx as a Perianal Implant for the Treatment of Persistent Fecal Incontience After Anorectal Malformation	Phase 4
Completed	`NCT00124904` - Biofeedback for Fecal Incontinence	N/A
Completed	`NCT03028636` - LIBERATE - PRO: Eclipse™ System Registry
Completed	`NCT04097288` - Effects of Single Dose Citalopram and Reboxetine on Urethral and Anal Closure Function on Healthy Female Subjects	Phase 1
Completed	`NCT05621629` - Management of FI After Surgery of ARM
Withdrawn	`NCT04138602` - BTL Emsella Chair Versus Sham for the Treatment of Fecal Incontinence	N/A
Completed	`NCT04478799` - Transcutaneous Posterior Nerve Stimulation inTreatment of Fecal Incontience	N/A
Completed	`NCT03252951` - Physical Therapy for Anal Incontinence	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.